Christine Uy
Adult Health · Providence, RINPI 1669888046
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by AbbVie at 48.3% of the total. Reporting peaked in 2021 at $2,199 and has fallen 94.5% since, to $121 in 2025. Among adult health clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $39.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Livanova USA, Inc.$498
- Biohaven Pharmaceutical Holding Company Ltd.$334
- Novartis$175
- Biogen$150
- Biohaven Pharmaceuticals, Inc.$139
- plus $662 from 15 others
What the payments were for
- Consulting fees$1504%
- Speaking & faculty fees$1,26433%
- Travel & lodging$2326%
- Food & beverage$2,14257%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $1,829 |
| Livanova USA, Inc. | 3 | $498 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $334 |
| Novartis | 16 | $175 |
| Biogen | 1 | $150 |
| Biohaven Pharmaceuticals, Inc. | 6 | $139 |
| Neurocrine Biosciences, Inc. | 1 | $123 |
| Eisai Inc. | 5 | $98 |
| Teva Pharmaceuticals USA, Inc. | 5 | $94 |
| SK Life Science, Inc. | 2 | $54 |
| Upsher-smith Laboratories LLC | 2 | $48 |
| Lilly USA, LLC | 2 | $40 |
| Amgen | 1 | $38 |
| Amneal Pharmaceuticals LLC | 2 | $32 |
| GE HealthCare | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Avion Pharmaceuticals | 1 | $19 |
| Sanofi | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Acorda Therapeutics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$1,250
- VNS Therapy$404
- NURTEC ODT$238
- TYSABRI$150
- INGREZZA$123
How this compares
$3,787 in reported general payments places this provider in the 90th percentile of 65 adult health providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 43 | $559 |
| Gabapentin | 29 | $493 |
| Memantine Hcl | 12 | $407 |
| Oxycodone Hcl | 51 | $246 |
| Levetiracetam | 11 | $216 |
| Meloxicam | 21 | $83 |
Paid to pharmacies, not to this prescriber.
Other adult health in Providence
- Phina MayuProvidence$2K
- Beverly CasinelliProvidence$935
- Rebecca CarleyProvidence$547
- Leanne BurkeProvidence$298
- Andrea ConnorsProvidence$228
- Patricia Shea LearyProvidence$184
- Jasmine HumphreyProvidence$181
- Erin HoughProvidence$179
- Rosemary DeverProvidence$124
- Sheila MartinProvidence$124
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.